Relpax 40 mg
Relpax 40 mg is a medicine authorised by Swissmedic under authorisation number 55218. The authorisation holder is Viatris Pharma GmbH. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 14 December 2000 and the authorisation is valid without a time limit. ATC code N02CC06 places the medicine in the group Analgesics.
| Authorisation number | 55218 |
|---|---|
| Name | Relpax 40 mg |
| Full name | Relpax 40 mg, Filmtabletten |
| Authorisation holder | Viatris Pharma GmbH |
| Medicinal product code | Synthetic medicines |
| Dispensing category | B · Prescription only |
| ATC code | N02CC06 |
| First authorisation | 14 December 2000 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 2 | Relpax 40 mg, Filmtabletten | B | 14 December 2000 |
| 3 | Relpax 80 mg, Filmtabletten | B | 16 May 2001 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 3 | 4 | Tablette(n) | N02CC06 | 02.05.1. | B |
| 5 | 6 | Tablette(n) | N02CC06 | 02.05.1. | B |
| 9 | 20 | Tablette(n) | N02CC06 | 02.05.1. | B |
| 7 | 6 | Tablette(n) | N02CC06 | 02.05.1. | B |
| 11 | 20 | Tablette(n) | N02CC06 | 02.05.1. | B |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Relpax 40 mg authorised in Switzerland?
Yes. Relpax 40 mg is authorised by Swissmedic under authorisation number 55218, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Relpax 40 mg have?
Relpax 40 mg is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Relpax 40 mg?
The authorisation holder is Viatris Pharma GmbH. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.